Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. It develops CAN-2409, which is in Phase II clinical trials for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the treatment of lung cancer, as well as has completed Phase Ib/II clinical trials for the treatment of high-grade glioma. The company also develops CAN-3110, which is in Phase I clinical trials for the treatment of recurrent high-grade glioma. It also develops the"enLIGHTEN Discovery Platform, a systematic, iterative HSV-based discovery platform leveraging human biology and advanced analytics to create new viral immunotherapies for solid tumors. The company was formerly known as Advantagene, Inc. and changed its name to Candel Therapeutics, Inc. in November 2020. Candel Therapeutics, Inc. was incorporated in 2003 and is headquartered in Needham, Massachusetts. more
Time Frame | CADL | Sector | S&P500 |
---|---|---|---|
1-Week Return | 31.32% | -2.27% | -0.57% |
1-Month Return | 57.34% | -3.96% | 1.21% |
3-Month Return | -3.71% | -9.7% | 7.57% |
6-Month Return | -10.48% | -3.37% | 11.45% |
1-Year Return | 467.23% | 3.71% | 28.48% |
3-Year Return | -10% | 3.8% | 29.52% |
5-Year Return | -3.57% | 39.78% | 90.66% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 125.00K | 125.00K | 125.00K | 125.00K | 31.00K | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":24.8,"profit":true}] |
Cost of Revenue | 6.61M | - | 232.00K | 987.00K | 23.98M | [{"date":"2019-12-31","value":27.55,"profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":0.97,"profit":true},{"date":"2022-12-31","value":4.12,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | (6.48M) | 125.00K | 125.00K | (862.00K) | (23.98M) | [{"date":"2019-12-31","value":-5185.6,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-689.6,"profit":false},{"date":"2023-12-31","value":-19184,"profit":false}] |
Gross Margin | (5185.60%) | 100.00% | 100.00% | (689.60%) | (77354.84%) | [{"date":"2019-12-31","value":-5185.6,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-689.6,"profit":false},{"date":"2023-12-31","value":-77354.84,"profit":false}] |
Operating Expenses | 8.59M | 13.31M | 25.85M | 34.80M | 14.41M | [{"date":"2019-12-31","value":24.69,"profit":true},{"date":"2020-12-31","value":38.25,"profit":true},{"date":"2021-12-31","value":74.29,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":41.41,"profit":true}] |
Operating Income | (9.04M) | (13.81M) | (25.73M) | (34.72M) | (38.39M) | [{"date":"2019-12-31","value":-903700000,"profit":false},{"date":"2020-12-31","value":-1381000000,"profit":false},{"date":"2021-12-31","value":-2572600000,"profit":false},{"date":"2022-12-31","value":-3472200000,"profit":false},{"date":"2023-12-31","value":-3839100000,"profit":false}] |
Total Non-Operating Income/Expense | 1.87M | (3.76M) | (10.45M) | 15.44M | 422.00K | [{"date":"2019-12-31","value":12.09,"profit":true},{"date":"2020-12-31","value":-24.35,"profit":false},{"date":"2021-12-31","value":-67.7,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":2.73,"profit":true}] |
Pre-Tax Income | (8.24M) | (17.68M) | (36.12M) | (18.79M) | (37.94M) | [{"date":"2019-12-31","value":-824000000,"profit":false},{"date":"2020-12-31","value":-1768000000,"profit":false},{"date":"2021-12-31","value":-3612400000,"profit":false},{"date":"2022-12-31","value":-1879400000,"profit":false},{"date":"2023-12-31","value":-3793900000,"profit":false}] |
Income Taxes | (226.00K) | 4.49M | 10.40M | (15.93M) | - | [{"date":"2019-12-31","value":-2.17,"profit":false},{"date":"2020-12-31","value":43.22,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-153.18,"profit":false},{"date":"2023-12-31","value":"-","profit":true}] |
Income After Taxes | (8.01M) | (22.17M) | (46.52M) | (2.87M) | - | [{"date":"2019-12-31","value":-801400000,"profit":false},{"date":"2020-12-31","value":-2217400000,"profit":false},{"date":"2021-12-31","value":-4652200000,"profit":false},{"date":"2022-12-31","value":-286600000,"profit":false},{"date":"2023-12-31","value":"-","profit":true}] |
Income From Continuous Operations | (8.24M) | (17.68M) | (36.12M) | (18.79M) | (31.93M) | [{"date":"2019-12-31","value":-824000000,"profit":false},{"date":"2020-12-31","value":-1768000000,"profit":false},{"date":"2021-12-31","value":-3612400000,"profit":false},{"date":"2022-12-31","value":-1879400000,"profit":false},{"date":"2023-12-31","value":-3192700000,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (8.01M) | (22.17M) | (36.12M) | (2.87M) | (37.94M) | [{"date":"2019-12-31","value":-801400000,"profit":false},{"date":"2020-12-31","value":-2217400000,"profit":false},{"date":"2021-12-31","value":-3612400000,"profit":false},{"date":"2022-12-31","value":-286600000,"profit":false},{"date":"2023-12-31","value":-3793900000,"profit":false}] |
EPS (Diluted) | - | - | (0.61) | (1.12) | (1.33) | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-60.74,"profit":false},{"date":"2022-12-31","value":-112,"profit":false},{"date":"2023-12-31","value":-133,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
CADL | |
---|---|
Cash Ratio | 1.08 |
Current Ratio | 1.18 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
CADL | |
---|---|
ROA (LTM) | -52.31% |
ROE (LTM) | -480.68% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
CADL | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 1.71 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | -0.71 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
CADL | |
---|---|
Trailing PE | NM |
Forward PE | 45.05 |
P/S (TTM) | 436.42 |
P/B | 30.41 |
Price/FCF | NM |
EV/R | 821.98 |
EV/Ebitda | NM |
Candel Therapeutics Inc (CADL) share price today is $6.75
Yes, Indians can buy shares of Candel Therapeutics Inc (CADL) on Vested. To buy Candel Therapeutics Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in CADL stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Candel Therapeutics Inc (CADL) via the Vested app. You can start investing in Candel Therapeutics Inc (CADL) with a minimum investment of $1.
You can invest in shares of Candel Therapeutics Inc (CADL) via Vested in three simple steps:
The 52-week high price of Candel Therapeutics Inc (CADL) is $14.3. The 52-week low price of Candel Therapeutics Inc (CADL) is $1.02.
The price-to-earnings (P/E) ratio of Candel Therapeutics Inc (CADL) is
The price-to-book (P/B) ratio of Candel Therapeutics Inc (CADL) is 30.41
The dividend yield of Candel Therapeutics Inc (CADL) is 0.00%
The market capitalization of Candel Therapeutics Inc (CADL) is $134.29M
The stock symbol (or ticker) of Candel Therapeutics Inc is CADL